Selected research
Market Structure
Global Allopurinol Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Allopurinol Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Allopurinol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Allopurinol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Allopurinol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Allopurinol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Allopurinol Tablets include Teva, Sun Pharmaceutical, Mylan, Zydus Pharmaceuticals, NorthStar Healthcare, Ipca Laboratories, Dr. Reddys Laboratories, Casper Pharma and APOTEX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Allopurinol Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Allopurinol Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Allopurinol Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Allopurinol Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Allopurinol Tablets Segment by Company
Teva
Sun Pharmaceutical
Mylan
Zydus Pharmaceuticals
NorthStar Healthcare
Ipca Laboratories
Dr. Reddys Laboratories
Casper Pharma
APOTEX
Accord Healthcare
Allopurinol Tablets Segment by Type
100 mg
300 mg
Allopurinol Tablets Segment by Application
Gout
Kidney Stones
Allopurinol Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allopurinol Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allopurinol Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allopurinol Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Allopurinol Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allopurinol Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Allopurinol Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Allopurinol Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 100 mg
- 300 mg
Applications
- Gout
- Kidney Stones
Companies covered
- Teva
- Sun Pharmaceutical
- Mylan
- Zydus Pharmaceuticals
- NorthStar Healthcare
- Ipca Laboratories
- Dr. Reddys Laboratories
- Casper Pharma
- APOTEX
- Accord Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Allopurinol Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Allopurinol Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Allopurinol Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Allopurinol Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Allopurinol Tablets Market Dynamics
- 2.1 Allopurinol Tablets Industry Trends
- 2.2 Allopurinol Tablets Industry Drivers
- 2.3 Allopurinol Tablets Industry Opportunities and Challenges
- 2.4 Allopurinol Tablets Industry Restraints
3 Allopurinol Tablets Market by Manufacturers
- 3.1 Global Allopurinol Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Allopurinol Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Allopurinol Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Allopurinol Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Allopurinol Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Allopurinol Tablets Manufacturers, Product Type & Application
- 3.7 Global Allopurinol Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Allopurinol Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Allopurinol Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Allopurinol Tablets Tier 1, Tier 2, and Tier 3
4 Allopurinol Tablets Market by Type
- 4.1 Allopurinol Tablets Type Introduction
- 4.1.1 100 mg
- 4.1.2 300 mg
- 4.2 Global Allopurinol Tablets Sales by Type
- 4.2.1 Global Allopurinol Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Allopurinol Tablets Sales by Type (2021-2032)
- 4.2.3 Global Allopurinol Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Allopurinol Tablets Revenue by Type
- 4.3.1 Global Allopurinol Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Allopurinol Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Allopurinol Tablets Revenue Market Share by Type (2021-2032)
5 Allopurinol Tablets Market by Application
- 5.1 Allopurinol Tablets Application Introduction
- 5.1.1 Gout
- 5.1.2 Kidney Stones
- 5.2 Global Allopurinol Tablets Sales by Application
- 5.2.1 Global Allopurinol Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Allopurinol Tablets Sales by Application (2021-2032)
- 5.2.3 Global Allopurinol Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Allopurinol Tablets Revenue by Application
- 5.3.1 Global Allopurinol Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Allopurinol Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Allopurinol Tablets Revenue Market Share by Application (2021-2032)
6 Global Allopurinol Tablets Sales by Region
- 6.1 Global Allopurinol Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Allopurinol Tablets Sales by Region (2021-2032)
- 6.2.1 Global Allopurinol Tablets Sales by Region (2021-2026)
- 6.2.2 Global Allopurinol Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Allopurinol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Allopurinol Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Allopurinol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Allopurinol Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Allopurinol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Allopurinol Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Allopurinol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Allopurinol Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Allopurinol Tablets Revenue by Region
- 7.1 Global Allopurinol Tablets Revenue by Region
- 7.1.1 Global Allopurinol Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Allopurinol Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Allopurinol Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Allopurinol Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Allopurinol Tablets Revenue (2021-2032)
- 7.2.2 North America Allopurinol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Allopurinol Tablets Revenue (2021-2032)
- 7.3.2 Europe Allopurinol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Allopurinol Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Allopurinol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Allopurinol Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Allopurinol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Allopurinol Tablets Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Sun Pharmaceutical
- 8.2.1 Sun Pharmaceutical Company Information
- 8.2.2 Sun Pharmaceutical Business Overview
- 8.2.3 Sun Pharmaceutical Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sun Pharmaceutical Allopurinol Tablets Product Portfolio
- 8.2.5 Sun Pharmaceutical Recent Developments
- 8.3 Mylan
- 8.3.1 Mylan Company Information
- 8.3.2 Mylan Business Overview
- 8.3.3 Mylan Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mylan Allopurinol Tablets Product Portfolio
- 8.3.5 Mylan Recent Developments
- 8.4 Zydus Pharmaceuticals
- 8.4.1 Zydus Pharmaceuticals Company Information
- 8.4.2 Zydus Pharmaceuticals Business Overview
- 8.4.3 Zydus Pharmaceuticals Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Zydus Pharmaceuticals Allopurinol Tablets Product Portfolio
- 8.4.5 Zydus Pharmaceuticals Recent Developments
- 8.5 NorthStar Healthcare
- 8.5.1 NorthStar Healthcare Company Information
- 8.5.2 NorthStar Healthcare Business Overview
- 8.5.3 NorthStar Healthcare Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 NorthStar Healthcare Allopurinol Tablets Product Portfolio
- 8.5.5 NorthStar Healthcare Recent Developments
- 8.6 Ipca Laboratories
- 8.6.1 Ipca Laboratories Company Information
- 8.6.2 Ipca Laboratories Business Overview
- 8.6.3 Ipca Laboratories Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Ipca Laboratories Allopurinol Tablets Product Portfolio
- 8.6.5 Ipca Laboratories Recent Developments
- 8.7 Dr. Reddys Laboratories
- 8.7.1 Dr. Reddys Laboratories Company Information
- 8.7.2 Dr. Reddys Laboratories Business Overview
- 8.7.3 Dr. Reddys Laboratories Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Dr. Reddys Laboratories Allopurinol Tablets Product Portfolio
- 8.7.5 Dr. Reddys Laboratories Recent Developments
- 8.8 Casper Pharma
- 8.8.1 Casper Pharma Company Information
- 8.8.2 Casper Pharma Business Overview
- 8.8.3 Casper Pharma Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Casper Pharma Allopurinol Tablets Product Portfolio
- 8.8.5 Casper Pharma Recent Developments
- 8.9 APOTEX
- 8.9.1 APOTEX Company Information
- 8.9.2 APOTEX Business Overview
- 8.9.3 APOTEX Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 APOTEX Allopurinol Tablets Product Portfolio
- 8.9.5 APOTEX Recent Developments
- 8.10 Accord Healthcare
- 8.10.1 Accord Healthcare Company Information
- 8.10.2 Accord Healthcare Business Overview
- 8.10.3 Accord Healthcare Allopurinol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Accord Healthcare Allopurinol Tablets Product Portfolio
- 8.10.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Allopurinol Tablets Value Chain Analysis
- 9.1.1 Allopurinol Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Allopurinol Tablets Production Mode & Process
- 9.2 Allopurinol Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Allopurinol Tablets Distributors
- 9.2.3 Allopurinol Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst